The Business of biosciences March 25, 2017
News from Asia
A trial with the new vaccine was conducted in Niger with 67 percent efficacy.
Sutezolid is the first TB drug added in the portfolio of Medicines Patent Pool.
The main advantage of this new program is that it is able to detect cancer at an early stage with an accuracy rate of 80 percent.